Boston Scientific Corporation (BSX) vs DexCom, Inc. (DXCM)
Boston Scientific Corporation and DexCom, Inc. are both Medical Devices companies. Boston Scientific Corporation is the larger, with a market value of $64.7B against $33.0B — 2.0× the size. Boston Scientific Corporation trades at the lower P/E: 17.7× against 33.4×. DexCom, Inc. grew revenue faster over the last twelve months: 15.5% against 13.5%. DexCom, Inc. has the higher net margin (20.1% vs 17.5%) and the higher return on invested capital (37.1% vs 6.96%). Across the 22 metrics below, DexCom, Inc. leads on 12 and Boston Scientific Corporation on 10.
Valuation
Profitability
| Metric | BSX | DXCM | Medical Devices median |
|---|---|---|---|
| Gross margin | 69.92% | 62.47% | 56.01% |
| Operating margin | 19.76% | 22.92% | (15.03%) |
| Net margin | 17.50% | 20.12% | (20.40%) |
| Free cash flow margin | 17.27% | 28.27% | (7.24%) |
| Return on equity | 15.37% | 38.49% | (15.32%) |
| Return on assets | 8.47% | 14.51% | (19.72%) |
| Return on invested capital | 6.96% | 37.13% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack